Skip to main navigation Skip to search Skip to main content

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

  • Warner K. Huh
  • , Elmar A. Joura
  • , Anna R. Giuliano
  • , Ole Erik Iversen
  • , Rosires Pereira de Andrade
  • , Kevin A. Ault
  • , Deborah Bartholomew
  • , Ramon M. Cestero
  • , Edison N. Fedrizzi
  • , Angelica L. Hirschberg
  • , Marie Hélène Mayrand
  • , Angela Maria Ruiz-Sternberg
  • , Jack T. Stapleton
  • , Dorothy J. Wiley
  • , Alex Ferenczy
  • , Robert Kurman
  • , Brigitte M. Ronnett
  • , Mark H. Stoler
  • , Jack Cuzick
  • , Suzanne M. Garland
    • Susanne K. Kjaer, Oliver M. Bautista, Richard Haupt, Erin Moeller, Michael Ritter, Christine C. Roberts, Christine Shields, Alain Luxembourg

Research output: Contribution to Journal › Research Article › peer-review

426   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science